|
WO2006065495A2
(en)
|
2004-11-24 |
2006-06-22 |
Fred Hutchinson Cancer Research Center |
Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
WO2016081518A2
(en)
|
2014-11-17 |
2016-05-26 |
Adicet Bio, Inc. |
Engineered gamma delta t-cells
|
|
CN107531787B
(zh)
|
2015-01-27 |
2022-01-18 |
拉法医疗有限公司 |
靶向cd1d的单域抗体
|
|
GB201507368D0
(en)
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
KR102663157B1
(ko)
|
2015-06-09 |
2024-05-13 |
감마델타 테라퓨틱스 엘티디 |
Ｔｃｒ감마 델타 양성 ｔ 세포의 생산 방법
|
|
EP4295914A3
(en)
|
2015-09-03 |
2024-04-10 |
The UAB Research Foundation |
Genetically-engineered drug resistant t cells and methods of using the same
|
|
EP3454870A4
(en)
|
2016-05-12 |
2020-03-04 |
Adicet Bio Inc. |
METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF
|
|
US10456423B2
(en)
|
2016-06-13 |
2019-10-29 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
US10426796B2
(en)
*
|
2016-06-13 |
2019-10-01 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
NZ750256A
(en)
|
2016-08-03 |
2026-02-27 |
Dipersio John F |
Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
|
|
KR102032354B1
(ko)
|
2016-11-11 |
2019-10-16 |
가톨릭대학교 산학협력단 |
신규한 배양보조세포 및 이를 이용한 감마 델타 ｔ 세포의 증식 방법
|
|
US11851491B2
(en)
|
2016-11-22 |
2023-12-26 |
TCR2 Therapeutics Inc. |
Compositions and methods for TCR reprogramming using fusion proteins
|
|
JP2020513754A
(ja)
*
|
2016-12-21 |
2020-05-21 |
ティーシーアール２ セラピューティクス インク． |
がん治療用に操作されたｔ細胞
|
|
EP3580331B1
(en)
*
|
2017-02-08 |
2022-06-01 |
Agency For Science, Technology And Research |
Gamma delta t cells and a method of augmenting the tumoricidal activity of the same
|
|
EP3595683A1
(en)
|
2017-03-15 |
2020-01-22 |
Orca Biosystems, Inc. |
Compositions and methods for hematopoietic stem cell transplants
|
|
GB201707048D0
(en)
*
|
2017-05-03 |
2017-06-14 |
King S College London |
Expansion of gamma delta cells, compositions, and methods of use thereof
|
|
US12384830B2
(en)
*
|
2017-06-02 |
2025-08-12 |
Regents Of The University Of Minnesota |
Compositions and methods for improving immunotherapy
|
|
WO2018236986A1
(en)
*
|
2017-06-20 |
2018-12-27 |
The Trustees Of Columbia University In The City Of New York |
Engineered t-cell receptors and methods of their use
|
|
SG11201912240QA
(en)
|
2017-06-28 |
2020-01-30 |
Regeneron Pharma |
Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use thereof
|
|
EP3681996B1
(en)
*
|
2017-09-15 |
2024-08-07 |
King's College London |
Compositions and methods for enhancing gamma delta t cells in the gut
|
|
TWI687227B
(zh)
*
|
2017-10-03 |
2020-03-11 |
生倍科技股份有限公司 |
用於t細胞免疫療法之組合及其用途
|
|
CN109777778B
(zh)
*
|
2017-11-14 |
2023-07-18 |
中国科学院广州生物医药与健康研究院 |
一种基因改造的γδT细胞
|
|
WO2019099744A1
(en)
|
2017-11-15 |
2019-05-23 |
Adicet Bio, Inc. |
METHODS FOR SELECTIVE EXPANSION OF δ3 γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
CN108129566B
(zh)
*
|
2017-12-31 |
2021-05-11 |
中国科学院武汉病毒研究所 |
靶向间皮素的c-型单域抗体及其制备方法与应用
|
|
EP3765054A4
(en)
*
|
2018-01-19 |
2022-01-12 |
The Trustees Of The University Of Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T LYMPHOCYTES USING CHIMERIC ANTIGEN RECEPTORS
|
|
US12077598B2
(en)
|
2018-03-16 |
2024-09-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Chimeric antigen receptors with mutated CD28 phosphorylation sites
|
|
GB201804701D0
(en)
|
2018-03-23 |
2018-05-09 |
Gammadelta Therapeutics Ltd |
Lymphocytes expressing heterologous targeting constructs
|
|
CN112218945A
(zh)
*
|
2018-05-08 |
2021-01-12 |
国立大学法人大阪大学 |
纯合细胞的制作方法
|
|
CN110577932A
(zh)
*
|
2018-06-07 |
2019-12-17 |
亘喜生物科技（上海）有限公司 |
一种脐带血来源的嵌合抗原受体t细胞
|
|
EA202190304A1
(ru)
*
|
2018-07-18 |
2022-01-21 |
Эмджен Инк. |
Химерные рецепторы к steap1 и способы их применения
|
|
HRP20260034T1
(hr)
*
|
2018-08-01 |
2026-02-27 |
Imcheck Therapeutics |
Anti-btn3a antitijela i njihova upotreba u liječenju raka ili infektivnih poremećaja
|
|
CN108949685B
(zh)
*
|
2018-08-02 |
2022-03-29 |
吉林大学第一医院 |
一种体外诱导扩增高杀伤活性γδT细胞的方法
|
|
US12156888B2
(en)
|
2018-08-07 |
2024-12-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CAR T-cells for the treatment of bone metastatic cancer
|
|
US12569507B2
(en)
*
|
2018-08-07 |
2026-03-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CAR T-cells for the treatment of bone metastatic cancer
|
|
CN112105724A
(zh)
*
|
2018-08-09 |
2020-12-18 |
深圳华大生命科学研究院 |
无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
|
|
PT3835415T
(pt)
*
|
2018-08-10 |
2024-12-18 |
Univ Kyoto |
Método para produção de células positivas para cd3
|
|
CN113307872B
(zh)
*
|
2018-08-11 |
2022-12-06 |
广东天科雅生物医药科技有限公司 |
一种工程化核酸、t细胞及其应用和产生方法
|
|
CN109161533B
(zh)
*
|
2018-08-28 |
2020-07-24 |
深圳市菲鹏生物制药股份有限公司 |
无血清培养组合物及其应用
|
|
WO2020060406A1
(en)
|
2018-09-19 |
2020-03-26 |
Lava Therapeutics B.V. |
Novel bispecific antibodies for use in the treatment of hematological malignancies
|
|
AU2019354391A1
(en)
*
|
2018-10-01 |
2021-05-06 |
Adicet Therapeutics, Inc. |
Compositions and methods regarding engineered and non- engineered γδ-Τ cells for treatment of hematological tumors
|
|
CN113272016A
(zh)
|
2018-10-01 |
2021-08-17 |
阿迪塞特生物股份有限公司 |
关于治疗实体肿瘤的工程化和非工程化γδ-T细胞的组合物和方法
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
KR102933479B1
(ko)
|
2018-10-23 |
2026-03-04 |
리제너론 파아마슈티컬스, 인크. |
Ny-eso-1 t 세포 수용체 및 이의 사용 방법
|
|
GB201818243D0
(en)
|
2018-11-08 |
2018-12-26 |
Gammadelta Therapeutics Ltd |
Methods for isolating and expanding cells
|
|
WO2020117862A1
(en)
|
2018-12-03 |
2020-06-11 |
Adicet Bio, Inc. |
Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof
|
|
CN111544585B
(zh)
*
|
2019-02-11 |
2024-12-27 |
北京卡替医疗技术有限公司 |
一种可助推免疫细胞在体内扩增的佐剂
|
|
JP6884450B2
(ja)
*
|
2019-02-14 |
2021-06-09 |
学校法人獨協学園獨協医科大学 |
Ｔ細胞ワクチン
|
|
CA3130489A1
(en)
*
|
2019-02-18 |
2020-08-27 |
Memorial Sloan-Kettering Cancer Center |
Combinations of multiple chimeric antigen receptors for immunotherapy
|
|
CA3130442A1
(en)
*
|
2019-02-24 |
2020-08-27 |
Gamida Cell Ltd. |
Method of homing and retention of gammadelta t cells for generating cell compositions for use in therapy
|
|
WO2020182681A1
(en)
*
|
2019-03-08 |
2020-09-17 |
Klinikum Der Universität München |
Ccr8 expressing lymphocytes for targeted tumor therapy
|
|
CN109758590B
(zh)
*
|
2019-03-28 |
2022-02-11 |
广东工业大学 |
一种用于筛选人前列腺癌肿瘤抗原表位肽的方法
|
|
CA3132028A1
(en)
*
|
2019-03-30 |
2020-10-08 |
Biontech Us Inc. |
Compositions and methods for preparing t cell compositions and uses thereof
|
|
US12404331B2
(en)
|
2019-04-19 |
2025-09-02 |
Tcrcure Biopharma Corp. |
Anti-PD-1 antibodies and uses thereof
|
|
JP2022529380A
(ja)
*
|
2019-04-26 |
2022-06-21 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用
|
|
EP3965818A4
(en)
*
|
2019-05-08 |
2023-05-31 |
Janssen Biotech, Inc. |
MATERIALS AND METHODS FOR MODULATION OF T-CELL-MEDIATED IMMUNITY
|
|
EP3999187A4
(en)
*
|
2019-07-17 |
2023-07-19 |
Case Western Reserve University |
LONG-LASTING T-CELLS FOR THE TREATMENT OF HIV INFECTION
|
|
WO2021016652A1
(en)
*
|
2019-07-29 |
2021-02-04 |
The University Of Melbourne |
METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
|
|
CA3145523A1
(en)
*
|
2019-08-16 |
2021-02-25 |
GammaDelta Therapeutics Limited |
Therapeutic uses of anti-tcr delta variable 1 antibodies
|
|
EP4045635A4
(en)
*
|
2019-10-17 |
2023-10-25 |
The University of Hong Kong |
METHODS FOR PREPARING EXOSOMES DERIVED FROM T-V LYMPHOCYTES FOR THE TREATMENT OF CANCERS ASSOCIATED WITH EPSTEIN-BARR VIRUS
|
|
US20210130461A1
(en)
|
2019-10-31 |
2021-05-06 |
Morphosys Ag |
Anti-tumor combination therapy comprising anti-cd19 antibody and gamma delta t-cells
|
|
JP2023504185A
(ja)
*
|
2019-12-03 |
2023-02-01 |
アディセット バイオ， インコーポレイテッド |
γδＴ細胞集団を多価薬剤で増殖させるための方法及びその組成物
|
|
IL294988A
(en)
|
2020-01-24 |
2022-09-01 |
Regeneron Pharma |
Antigen preferentially expressed in melanoma t-cell receptors (prame) and methods of using them
|
|
GB202002581D0
(en)
*
|
2020-02-24 |
2020-04-08 |
Gammadelta Therapeutics Ltd |
Novel antibodies
|
|
WO2021176373A1
(en)
*
|
2020-03-03 |
2021-09-10 |
Janssen Biotech, Inc. |
ꝩδ T CELLS AND USES THEREOF
|
|
US12365871B2
(en)
|
2020-04-28 |
2025-07-22 |
Lyell Immunopharma, Inc. |
Methods for culturing cells
|
|
US20230226181A1
(en)
*
|
2020-06-22 |
2023-07-20 |
Nanjing Legend Biotech Co., Ltd. |
GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY
|
|
CN116323667A
(zh)
|
2020-07-08 |
2023-06-23 |
拉法医疗股份有限公司 |
结合PSMA和γ-δT细胞受体的抗体
|
|
CN116333995A
(zh)
*
|
2020-07-14 |
2023-06-27 |
广州泛恩生物科技有限公司 |
基于cxcr6阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用
|
|
US20240115705A1
(en)
*
|
2021-02-08 |
2024-04-11 |
The J. Gladstone Institutes, a testamentary trust established under the will of J. David Gladstone |
Regulation of Butyrophilin subfamily 3 member A1 (BTN3A1, CD277)
|
|
GB202105113D0
(en)
*
|
2021-04-09 |
2021-05-26 |
Gammadelta Therapeutics Ltd |
Novel method
|
|
JP2024539088A
(ja)
*
|
2021-10-20 |
2024-10-28 |
ユニバーシティ オブ ピッツバーグ －オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
腫瘍浸潤ガンマ－デルタｔ細胞を拡大するための方法及び材料
|
|
WO2023092119A2
(en)
|
2021-11-22 |
2023-05-25 |
Ludwig Institute For Cancer Research Ltd |
Methods for predicting responsiveness to a cancer therapy
|
|
IL313297A
(en)
*
|
2021-12-05 |
2024-08-01 |
Adicet Therapeutics Inc |
Treatment of b cell malignancies
|
|
KR20230105166A
(ko)
|
2022-01-03 |
2023-07-11 |
주식회사 이뮤노맥스 |
감마-델타 t 세포의 증식 배양 방법
|
|
CN114149978B
(zh)
*
|
2022-02-09 |
2022-04-26 |
深圳博雅感知药业有限公司 |
制备car-t细胞的方法
|
|
MX2024010047A
(es)
|
2022-02-16 |
2024-08-26 |
Priothera Sas |
Metodos de tratamiento con celulas car en combinacion con moduladores del receptor s1p.
|
|
GB202204926D0
(en)
|
2022-04-04 |
2022-05-18 |
Gammadelta Therapeutics Ltd |
Method for expanding gammadelta T cells
|
|
US20260014199A1
(en)
*
|
2022-06-17 |
2026-01-15 |
Gadeta B.V. |
Modified immune cells
|
|
CN115624618A
(zh)
*
|
2022-09-16 |
2023-01-20 |
深圳善乐生物科技有限公司 |
一种HPV多肽抗原负载γδT细胞在HPV阳性宫颈癌免疫治疗中的应用
|
|
KR20250089551A
(ko)
|
2022-10-31 |
2025-06-18 |
리제너론 파마슈티칼스 인코포레이티드 |
입양 세포 요법과 표적 면역사이토카인을 조합하여 이용한 암 치료 방법
|
|
KR20250169609A
(ko)
|
2023-04-07 |
2025-12-03 |
리제너론 파마슈티칼스 인코포레이티드 |
림포톡신 β 수용체 작용제를 이용한 암 치료 방법
|
|
CN121335919A
(zh)
|
2023-05-25 |
2026-01-13 |
瑞泽恩制药公司 |
结合呈递的hpv16、mart1、cmv、ebv或流感肽的t细胞受体
|
|
US12221483B1
(en)
*
|
2024-01-30 |
2025-02-11 |
China Medical University Hospital |
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
|
|
WO2025165915A1
(en)
*
|
2024-01-31 |
2025-08-07 |
Adicet Therapeutics, Inc. |
Compositions and methods for enhancing engineered t cell therapies
|
|
WO2025223534A1
(en)
*
|
2024-04-26 |
2025-10-30 |
Nanjing Legend Biotech Co., Ltd. |
Methods for expanding t cells
|
|
WO2025229538A1
(en)
*
|
2024-05-01 |
2025-11-06 |
Janssen Biotech, Inc. |
Materials, methods, and systems for cellular expansion of gamma delta t-cells
|
|
WO2026013158A1
(en)
*
|
2024-07-10 |
2026-01-15 |
Cytospire Therapeutics Limited |
Antibodies binding to constant domains of gamma delta t-cell receptors
|
|
WO2026013159A1
(en)
*
|
2024-07-10 |
2026-01-15 |
Cytospire Therapeutics Limited |
Antibodies binding to constant domains of gamma delta t-cell receptors
|